ARCHIVES

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

NCCS Appointment Marks Transition To New Structure.

March 17, 2000

NCAB Rejects Automatic Loss Of Comprehensive Status For Center Without Core Grants

September 29, 1978

Study Finds Long-Term Remission In NHL With Tositumomab, Iodine I 131 With CHOP

December 30, 2005

NCI To Expand SPORE Grants Program to Increase Translational Research Funding

October 22, 1999

Greenwald Lists Plans For $40 Million Raise In Prevention & Control

December 3, 1993

AACR Supports 5 Percent Increase in NCI Budget.

April 7, 2006